Drugs / ESTROGENS, CONJUGATED SYNTHETIC A
ESTROGENS, CONJUGATED SYNTHETIC A
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (2) | US (FDA) | CENESTIN | — | 2002-06-21 – 2004-02-05 | fda.gov ↗ |
| Approved | US (FDA) | CENESTIN | — | 1999-03-24 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00272935 | Dec 2005 → May 2007 | — | Duramed Research | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ESTROGENS, CONJUGATED SYNTHETIC A | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201466 ↗ |
| Known as | Cenestin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00272935 ↗ |
| Known as | Synthetic conjugated estrogens a | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201466 ↗ |